DOI: https://doi.org/10.29296/25877313-2020-04-04
Download full text PDF

Authors, 2020 A.I. Odnovorov Post-graduate Student, Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, Peoples' Friendship University of Russia E-mail: mister.odn2010@yandex.ru T.V. Pletneva Dr.Sc. (Chem.), Professor, Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, Peoples' Friendship University of Russia M.A. Morozova Ph.D. (Chem.), Associate Professor, Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, Peoples' Friendship University of Russia

Objective. To identify and analyze the correlations between the structural features of APIs (active pharmaceutical ingredient) of influenza drugs and their biological activity. Materials and methods. Anti-influenza drugs: neuraminidase inhibitors, M2-channel blockers, hemagglutinin inhibitor, cap-dependent endonuclease inhibitor. For the correlation analysis, two topological indices were chosen - the Wiener index (W) and the Balaban index (J). To calculate the topological indices, the «ChemicDescript» program was used. A graphical representation of the results was performed using the Origin software package (OriginLab Corporation, USA). Results. The dependences “topological index - property” are analyzed for both individual substances and groups of anti-influenza drugs. A large degeneracy of the Wiener index was revealed - a linear correlation is observed for preparations of different chemical groups. The results confirm the possibility of using the Balaban index for homologous compounds, which is especially clearly demonstrated by the group of neuraminidase inhibitors. Conclusion. Dependencies between the structure (topological indices) and the biological properties of APIs were revealed, which can be further used to predict the properties and biological activity of new influenza drugs.

quantitative correlations "structure-property"
influenza virus
antiviral drugs

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

  1. Iuliano A.D., Roguski K.M., Chang H.H., et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018; 391(10127): 1285-300.
  2. Sulima D.L., Karev V.E., Zhdanov K.V. Gipertoksicheskij gripp. Zhurnal infektologii. 2010; 2(1): 75-79.
  3. Bearman G.M., Shankaran S., Elam K. Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy. Recent Pat Antiinfect Drug Discov. 2010; 5(2):152-156.
  4. Fiore A.E., Fry A., Shay D., et al. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011; 60(1):1-24.
  5. Hurt A.C., Holien J.K., Parker M.W., Barr I.G. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs. 2009; 69(18):2523-2531.
  6. Percival A. Impact of chemical structure on quinolone potency, spectrum and side effects. J. Antimicrob. Chemother. 1991; 28 Suppl C: 1-8.
  7. Karelson M. Molecular descriptors in QSAR/QSPR. John Wiley& Sons. New York. 2000. Р. 160-190.
  8. Lucić B., Lukovits I., Nikolić S., Trinajstić N. Distance-rela¬ted indexes in the quantitative structure-property relationship modeling. J. Chem. Inf. Comput. Sci. 2001; 41(3):527-35.
  9. Shibnev V.A., Garaev T.M., Finogenova M.P. i dr. Novyue proizvodnyue adamant, sposobnyue preodolet rezistentnost virusov grippa А(H1N1) pdm2009 i А(H3N2) k «remantadinu». Bulleten eksperimentalnoi biologii i meditsinyu. 2012; 153(2):200202.
  10. Shchelkanov M.Yu., Shibnev V.A., Finogenova M.P. i dr. Protivovirushuya aktivnost proizvodnyukh adamant v otnoshenii virusa grippa А(H1N1) pdm09 na modeli in vivo. Voprosy virusologii. 2014; 59(2):37-40.
  11. Popov P.I. Chemic Pen. Svidetelstvo ob ofitsialnoi registratsii program dlya EVM № 2005612073. Rospatent. 2005.
  12. Popov P.I. Chemic Descript. Svidetelstvo ob ofitsialnoi registratsii program dlya EVM № 2003612305. Rospatent. 2003.
  13. Wiener H. Structural Determination of Paraffin Boiling Points. J. Am. Chem. Soc. 1947; 69:17−20.
  14. Balaban A.T. Highly Discriminating Distance Based Topological Indices. Chem. Phys. Lett. 1982; 89:399-404.
  15. Gini G. QSAR: What Else? Methods Mol. Biol. 2018; 1800:79-105.
  16. Gini G. QSAR Methods. Methods Mol. Biol. 2016; 1425:1-20.